{"prompt": "['EudraCT Number 2019-002880-82, IRAS Number 1003208', 'For participants of GUARD MEC who are not part of the main trial, only adverse events', 'who are related to study procedures will be collected. This includes (but is not limited to)', 'allergic reactions to food, fainting, reactions to the CGM device, reactions of the phlebotomy,', 'etc.', 'AE will be collected from the day of the study procedure at week 36, until the time the', 'CGM device is disconnected, 10 days later. Severity will be assessed as mild, moderate', 'and severe.', 'GUARD protocol V1.0 11Mar20', 'Page 45 of 53']['EudraCT Number 2019-002880-82, IRAS Number 1003208', '20. References', '1.', 'HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, Dyer AR, Trimble ER,', 'Chaovarindr U, et al. Hyperglycemia and Adverse Pregnancy Outcomes. N Engl J Med', '2008;358:1991-2002.', '2.', 'Black MH, Sacks DA, Xiang AH, Lawrence JM. Clinical Outcomes of Pregnancies', 'Complicated by Mild Gestational Diabetes Mellitus Differ by Combinations of Abnormal Oral Glucose', 'Tolerance Test Values. Diabetes Care 2010;33:2524-30.', '3.', 'Tobias DK, Stuart JJ, Li S, Chavarro J, Rimm EB, Rich-Edwards J, et al. Association of', 'History of Gestational Diabetes With Long-term Cardiovascular Disease Risk in a Large Prospective', 'Cohort of US Women. JAMA Intern Med 2017;177:1735-42.', '4.', 'Albareda M, Caballero A, Badell G, Piquer S, Ortiz A, de Leiva A, et al. Diabetes and', 'abnormal glucose tolerance in women with previous gestational diabetes. Diabetes Care', '2003;26:1199-205.', '5.', 'Lowe WL, Scholtens DM, Lowe LP, Kuang A, Nodzenski M, Talbot O, et al. Association of', 'Gestational Diabetes With Maternal Disorders of Glucose Metabolism and Childhood Adiposity.', 'JAMA 2018;320:1005.', '6.', 'Ryckman K, Spracklen C, Smith C, Robinson J, Saftlas A. Maternal lipid levels during', 'pregnancy and gestational diabetes: a systematic review and meta-analysis. BJOG 2015;122:643-', '51.', '7.', 'White SL, Pasupathy D, Sattar N, Nelson SM, Lawlor DA, Briley AL, et al. Metabolic profiling', 'of gestational diabetes in obese women during pregnancy. Diabetologia 2017;60:1903-12.', '8.', 'Anderson SG, Dunn WB, Banerjee M, Brown M, Broadhurst DI, Goodacre R, et al. Evidence', 'That Multiple Defects in Lipid Regulation Occur before Hyperglycemia during the Prodrome of Type-', '2 Diabetes. PLoS One 2014;9:e103217.', '9.', 'Fasshauer M, Bl\u00fcher M, Stumvoll M. Adipokines in gestational diabetes. Lancet Diabetes', 'Endocrinol 2014;2:488-99.', '10.', 'Banerjee M, Anderson SG, Malik RA, Austin CE, Cruickshank JK. Small artery function 2', 'years postpartum in women with altered glycaemic distributions in their preceding pregnancy. Clin', 'Sci 2012;122:53-61.', '11.', \"O'Sullivan EP, Avalos G, O'Reilly M, Dennedy MC, Gaffney G, Dunne F, et al. Atlantic\", 'Diabetes in Pregnancy (DIP): the prevalence and outcomes of gestational diabetes mellitus using', 'new diagnostic criteria. Diabetologia 2011;54:1670-5.', '12.', 'Athukorala C, Crowther CA, Willson K, Australian Carbohydrate Intolerance Study in', 'Pregnant Women (ACHOIS) Trial Group. Women with gestational diabetes mellitus in the ACHOIS', 'trial: Risk factors for shoulder dystocia. Aust New Zeal J Obstet Gynaecol 2007;47:37-41.', '13.', 'Schaefer-Graf UM, Graf K, Kulbacka I, Kjos SL, Dudenhausen J, Vetter K, et al. Maternal', 'Lipids as Strong Determinants of Fetal Environment and Growth in Pregnancies With Gestational', 'Diabetes Mellitus. Diabetes Care 2008;31:1858-63.', '14.', 'Son GH, Kwon JY, Kim YH, Park YW. Maternal serum triglycerides as predictive factors for', 'large-forgestational age newborns in women with gestational diabetes mellitus. Acta Obstet', 'Gynecol Scand 2010;89:700-4.', 'GUARD protocol V1.0 11Mar20', 'Page 46 of 53']['EudraCT Number 2019-002880-82, IRAS Number 1003208', '15.', 'Harmon KA, Gerard L, Jensen DR, Kealey EH, Hernandez TL, Reece MS, et al. Continuous', 'Glucose Profiles in Obese and Normal-Weight Pregnant Women on a Controlled Diet: Metabolic', 'determinants of fetal growth. Diabetes Care 2011;34:2198-204.', '16.', 'Kawasaki M, Arata N, Miyazaki C, Mori R, Kikuchi T, Ogawa Y, et al. Obesity and abnormal', 'glucose tolerance in offspring of diabetic mothers: A systematic review and meta-analysis. PLoS', 'One 2018;13:e0190676.', '17.', 'Leybovitz-Haleluya N, Wainstock T, Landau D, Sheiner E. Maternal gestational diabetes', 'mellitus and the risk of subsequent pediatric cardiovascular diseases of the offspring: a population-', 'based cohort study with up to 18 years of follow up. Acta Diabetol 2018; doi: 10.1007/s00592-018-', '1176-1.', '18.', 'Sacco F, Calderone A, Castagnoli L, Cesareni G. The cell-autonomous mechanisms', 'underlying the activity of metformin as an anticancer drug. Br J Cancer 2016;115:1451-6.', '19.', 'Romero R, Erez O, H\u00fcttemann M, Maymon E, Panaitescu B, Conde-Agudelo A, et al.', 'Metformin, the aspirin of the 21st century: its role in gestational diabetes mellitus, prevention of', 'preeclampsia and cancer, and the promotion of longevity. Am J Obstet Gynecol 2017;217:282-', '302.', '20.', 'Rowan JA, Hague WM, Gao W, Battin MR, Moore MP, MiG Trial Investigators. Metformin', 'versus Insulin for the Treatment of Gestational Diabetes. N Engl J Med 2008;358:2003-15', '21.', 'Rowan JA, Rush EC, Obolonkin V, Battin M, Wouldes T, Hague WM. Metformin in', 'Gestational Diabetes: The Offspring Follow-Up (MiG TOFU): Body composition at 2 years of age.', 'Diabetes Care 2011;34:2279-8', '22.', 'Vanky E, Stridsklev S, Heimstad R, Romundstad P, Skog\u00f8y K, Kleggetveit O, et al.', 'Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized,', 'controlled multicenter study. J Clin Endocrinol Metab 2010;95:E448-55.', '23.', 'Barbour LA, Scifres C, Valent AM, Friedman JE, Buchanan TA, Coustan D, et al. A', 'cautionary response to SMFM statement: pharmacological treatment of gestational diabetes. Am J', 'Obstet Gynecol 2018; doi:', '10.1016/j.ajog.2018.06.013.', '24.', 'van Weelden W, Wekker V, de Wit L, Limpens J, Ij\u00e4s H, van Wassenaer-Leemhuis AG, et', 'al. Long-Term Effects of Oral Antidiabetic Drugs During Pregnancy on Offspring: A Systematic', 'Review and Metaanalysis of Follow-up Studies of RCTs. Diabetes Ther [Internet]. 2018 [cited 2018', 'Sep 12]; Available from: http://www.ncbi.nlm.nih.gov/pubmed/30168045', '25.', 'Martis R, Crowther CA, Shepherd E, Alsweiler J, Downie MR, Brown J. Treatments for', 'women with gestational diabetes mellitus: an overview of Cochrane systematic reviews. Cochrane', 'Database Syst Rev 2018;8:CD012327.', '26.', 'Langer O, Conway DL, Berkus MD, Xenakis EM-J, Gonzales O. A Comparison of Glyburide', 'and Insulin in Women with Gestational Diabetes Mellitus. N Engl J Med 2000;343:1134-8.', '27.', 'Reynolds RM, Denison FC, Juszczak E, Bell JL, Penneycard J, Strachan MWJ, et al.', 'Glibenclamide and metfoRmin versus stAndard care in gEstational diabeteS (GRACES): a feasibility', 'open label randomised trial. BMC Pregnancy Childbirth 2017;17:316.', '28.', 'Bonde L, Vilsb\u00f8ll T, Nielsen T, Bagger JI, Svare JA, Holst JJ, et al. Reduced postprandial', 'GLP-1 responses in women with gestational diabetes mellitus. Diabetes, Obes Metab 2013;15:713-', '20.', '29.', 'Koren O, Goodrich JK, Cullender TC, Spor A, Laitinen K, B\u00e4ckhed HK, et al. Host remodeling', 'of the gut microbiome and metabolic changes during pregnancy. Cell 2012;150:470-80.', 'GUARD protocol V1.0 11Mar20', 'Page 47 of 53']\n\n###\n\n", "completion": "END"}